Stockscreener 앱 받기
4.42
0.90%
-0.04
전일 마감가:
$4.46
열려 있는:
$4.4
하루 거래량:
144.40K
Relative Volume:
0.05
시가총액:
$108.49M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-8.96%
1개월 성능:
-2.86%
6개월 성능:
+85.71%
1년 성능:
-34.81%
1일 변동 폭
$4.31
$4.48
1주일 범위
$4.31
$5.16
52주 변동 폭
$1.47
$7.46
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
명칭
Artiva Biotherapeutics Inc
전화
(858) 267-4467
주소
5505 MOREHOUSE DRIVE, SAN DIEGO
ARTV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
4.42 | 109.47M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 재개 | H.C. Wainwright | Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 개시 | Jefferies | Buy |
| 2024-08-13 | 개시 | Needham | Buy |
| 2024-08-13 | 개시 | TD Cowen | Buy |
| 2024-08-13 | 개시 | Wedbush | Outperform |
모두보기
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
Aug Catalysts: How do insiders feel about Artiva Biotherapeutics IncJuly 2025 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Take Profit: Can Artiva Biotherapeutics Inc outperform in the next rallyWeekly Market Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Wall Street Recap: Is AppTech Payments Corp Equity Warrant attractive for institutional investorsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Trend Recap: Will Artiva Biotherapeutics Inc outperform its industry peers2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Artiva Biotherapeutics Stock: Upcoming Data Presentations In Focus (NASDAQ:ARTV) - Seeking Alpha
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Growth in Short Interest - MarketBeat
Published on: 2026-01-14 12:03:58 - baoquankhu1.vn
Quarterly Trades: Will Artiva Biotherapeutics Inc. stock gain from lower inflationWeekly Profit Recap & AI Powered Trade Plan Recommendations - Bộ Nội Vụ
Valuation Update: Can Pineapple Financial Inc be recession proofQuarterly Investment Review & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Published on: 2026-01-14 05:34:55 - baoquankhu1.vn
Sjogren’s Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics - Barchart.com
Bearish Setup: Will EWCZ stock benefit from green energy trends2025 Price Targets & Accurate Entry and Exit Point Alerts - Bộ Nội Vụ
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN
Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Review & Low Drawdown Investment Strategies - Улправда
How Artiva Biotherapeutics Inc. stock performs in weak economyQuarterly Market Summary & Technical Entry and Exit Tips - Улправда
Is Artiva Biotherapeutics Inc. stock oversold or undervaluedQuarterly Risk Review & Growth Focused Investment Plans - ulpravda.ru
Is Artiva Biotherapeutics Inc. stock a good choice for value investorsOil Prices & Stepwise Swing Trade Plans - Улправда
How Artiva Biotherapeutics Inc. stock performs in high volatility marketsJuly 2025 Sentiment & Proven Capital Preservation Methods - Улправда
NanoSyrinx Appoints New CEO to Advance Nanosyringe Technology - Intellectia AI
Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3% – Should You Buy? - Defense World
Artiva Biotherapeutics expands board with industry veteran - MSN
Genelux Corporation Announces Appointment of Jason Litten as Chief Medical Officer, Effective January 2, 2026 - marketscreener.com
Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO’s Latest Insider Share Sale - Yahoo Finance
Will Artiva Biotherapeutics Inc. stock deliver long term returnsMarket Risk Summary & Reliable Entry Point Alerts - Улправда
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - MSN
Is Artiva Biotherapeutics Inc. stock undervalued vs historical averagesJuly 2025 PreEarnings & Technical Pattern Based Signals - DonanımHaber
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) dropped from NASDAQ Biotechnology Index - marketscreener.com
CEO Moves: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Big Picture & High Accuracy Swing Entry Alerts - Улправда
Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
Resistance Check: Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Safe Entry Trade Signal Reports - Улправда
ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView — Track All Markets
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics CEO sells $19,122 in stock By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
Insider Sell: Fred Aslan Sells Shares of Artiva Biotherapeutics Inc (ARTV) - GuruFocus
Insider Selling: Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells 3,187 Shares of Stock - MarketBeat
Artiva Biotherapeutics CEO sells $19,122 in stock - Investing.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
US Stocks Mixed; NY Manufacturing Activity Dips In December - Benzinga
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Artiva Biotherapeutics Executes RSU Exchange for Employees - TipRanks
Artiva Biotherapeutics Advances with Promising NK Cell Therapy Study - MSN
Artiva Biotherapeutics executes RSU exchange for employees - MSN
Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Nurix Therapeutics (NRIX) - The Globe and Mail
How Artiva Biotherapeutics Inc. stock trades before earningsPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Will Artiva Biotherapeutics Inc. stock outperform tech sector in 2025Trade Exit Report & Consistent Profit Trading Strategies - Newser
Risk Hedge: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Daily Growth Stock Tips - Bộ Nội Vụ
Artiva Biotherapeutics Inc (ARTV) 재무 분석
Artiva Biotherapeutics Inc (ARTV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):